The study of Luo et al. [105] has investigated that CXCL13 were sufficiently expressed in CRC tissues and positively correlated with clinicopathological features such as more advanced TNM stage, a greater depth of tumor invasion (T stage) and the presence of lymph node metastases (N stage) [105]. The gene discussed is CXCL13; the disease is colorectal carcinoma.